创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

ZHAO Junkai, WANG Dan, YE Baofen, YAN Ran, WANG Danli, XU Liyou, YANG Zheng, WANG Yue. Current Applications of Polydeoxyribonucleotide in Clinical Treatment and Medical AestheticsJ. Progress in Pharmaceutical Sciences, 2026, 50(7): 599-607. DOI: 10.20053/j.issn1001-5094.202512231033
Citation: ZHAO Junkai, WANG Dan, YE Baofen, YAN Ran, WANG Danli, XU Liyou, YANG Zheng, WANG Yue. Current Applications of Polydeoxyribonucleotide in Clinical Treatment and Medical AestheticsJ. Progress in Pharmaceutical Sciences, 2026, 50(7): 599-607. DOI: 10.20053/j.issn1001-5094.202512231033

Current Applications of Polydeoxyribonucleotide in Clinical Treatment and Medical Aesthetics

  • Polydeoxyribonucleotide(PDRN) is a mixture of degraded single-stranded oligodeoxynucleotides and has emerged as a major research focus in medical aesthetics and clinical treatment in recent years. This review summarizes the basic physicochemical properties, its mechanisms of action, and advances in its application of PDRN. It further delineates the current status of its application and development across a range of clinical indications and in the field of medical aesthetics, and discusses the available safety evidence and potential risks. This review aims to provide a reference for the standardized clinical use of PDRN and its development for medical aesthetic applications.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return